In July, Dr. Buckley received an R21 from the NIH/NHLBI through their “Bold New Bioengineering Methods and Approaches for Heart, Lung, Blood, and Sleep Disorders and Diseases” funding opportunity. Her proposal, entitled “Microvascular cerebral blood flow measured with diffuse correlation spectroscopy in children with sickle cell disease”, will assess the feasibility of a new, low-cost, non-invasive technology known as diffuse correlation spectroscopy, to quantify blood flow in the brain of sickle cell patients through a complementary set of experiments in model systems, mice with sickle cell disease, and human patients. The long-term goal of our research is to use diffuse correlation spectroscopy for longitudinal evaluation of blood flow in children with sickle cell disease in order to reduce the incidence of stroke, to guide therapies, and to ultimately improve outcomes. Dr. Buckley’s collaborators on this project include Dr. Wilbur Lam (Emory/GT, BME) and Dr. David Archer (Emory, Pediatrics).
-
Archives
- July 2023
- April 2023
- March 2023
- January 2023
- October 2022
- July 2022
- May 2022
- November 2021
- August 2021
- June 2021
- May 2021
- January 2021
- August 2020
- April 2020
- November 2019
- October 2019
- August 2019
- June 2019
- May 2019
- February 2019
- November 2018
- October 2018
- September 2018
- June 2018
- May 2018
- April 2018
- February 2018
- November 2017
- October 2017
- August 2017
- July 2017
- June 2017
- May 2017
- February 2017
- January 2017
- October 2016
- July 2016
- February 2016
- September 2015
- August 2015
- June 2015
-
Meta